Americans Are Worried About the Cost of Their Healthcare (and they have good reason)

By CASEY QUINLAN, HELEN HASKELL, BILL ADAMS, JOHN JAMES, ROBERT R. SCULLY, and POPPY ARFORD Last year, the Patient Council of the Right Care Alliance conducted a survey in which over 1,000 Americans answered questions about what worried them most about their healthcare. We asked questions about access to care, concerns about misdiagnosis, and risks of treatment, which we reported on in our last THCB piece about the What Worries You Most survey. We also asked people to rank their concerns about the costs of their care, in five questions that covered cost of care, cost of prescription drugs, cost and availability of insurance, and surprise billing. In the time since we ran the survey, everything has changed in American healthcare. The COVID19 pandemic is filling emergency rooms wherever the epidemic arrives. Bills are likely to be high, for both patients and insurers, and it is still far from clear how they will be paid. Americans are likely to continue to worry deeply about healthcare costs, with good reason, since it’s only in America that someone can go bankrupt due to seeking medical care. Below are the questions we asked, and some commentary on how survey sentiment might be impacted by the COVID19 pandemic: 1. I can’t afford my care if I become ill or injured. Sixty-six percent of our survey respondents said they were very or somewhat worried about affording care if they got sick, or were hurt. Even if you have “good insurance,” usua...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: COVID-19 Health Policy Bill Adams Casey Quinlan cost of care Costs Economics Health Care Costs Helen Haskell John James Patient Council of the Right Care Alliance Poppy Arford Robert R. Scully Source Type: blogs

Related Links:

County commissioners told the Pittsburgh Business Times and other media outlets last week that they were told to expect targeted mitigation measures by Thursday.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Medical College of Wisconsin president and CEO Dr. John Raymond Sr. called “very troubling” the recent increase in new Covid-19 cases in Wisconsin, but said lagging indicators of the disease’s impact like hospitalizations and deaths are not alarming so far. The number of new diagnoses in Wisconsin jumped in recent days after a lull following the Fourth of July. Wisc onsin posted its four highest days for new cases from July 9 through Sunday ranging from 752 to 929. “Our early indicators…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
An Austin company has created a device that can measure someone's heart beat without any physical contact. The race is on to bring the product to market as the world deals with the coronavirus pandemic. Click through to learn more about their latest partnership.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
A biopharmaceutical company that has been working in collaboration with UAB on an intranasal Covid-19 vaccine candidate said preclinical studies of the candidate had positive results. Altimmune Inc., a Gaithersburg, Maryland-based firm, said the results showed strong neutralizing activity and potent immunity in the respiratory tract. The nasal injection in the respiratory tract may be necessary to block both infection and transmission of the virus and prevent further spread.  Based on the findings,…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
The mayor wants to avoid more restrictions on business, but that will depend on whether Covid-19 cases keep rising.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Cases rise by over 230,000 worldwide in 24 hours; 250,000 people in Manila to return to lockdown; Brazil cases near 2m‘Compelling’ evidence air pollution worsens coronavirus – studyGerman study finds low Covid-19 infection rate in schoolsFauci sidelined as Trump ’s White House steps up briefing campaignBereaved urge EU chief to supervise Italian coronavirus inquiry7.57pmBSTThe Trump administration is increasinglyat war with Anthony Fauci, the federal government ’s top public health expert, over the handling of the epidemic, as the US continues to report around 60,000 new cases a day.In what ap...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak World news US news UK news Australia news South Africa Brazil Science Infectious diseases Source Type: news
Conclusion: So far no pharmacological intervention was proven effective and safe to warrant its use in the routine treatment of COVID-19 patients; therefore such patients should ideally be treated in the context of clinical trials. The recommendations herein provided will be revised continuously aiming to capture newly generated evidence.
Source: Revista Brasileira de Terapia Intensiva - Category: Intensive Care Source Type: research
Conclusion: So far no pharmacological intervention was proven effective and safe to warrant its use in the routine treatment of COVID-19 patients; therefore such patients should ideally be treated in the context of clinical trials. The recommendations herein provided will be revised continuously aiming to capture newly generated evidence.
Source: Revista Brasileira de Terapia Intensiva - Category: Intensive Care Source Type: research
Conclusion: So far no pharmacological intervention was proven effective and safe to warrant its use in the routine treatment of COVID-19 patients; therefore such patients should ideally be treated in the context of clinical trials. The recommendations herein provided will be revised continuously aiming to capture newly generated evidence.
Source: Revista Brasileira de Terapia Intensiva - Category: Intensive Care Source Type: research
Conclusion: So far no pharmacological intervention was proven effective and safe to warrant its use in the routine treatment of COVID-19 patients; therefore such patients should ideally be treated in the context of clinical trials. The recommendations herein provided will be revised continuously aiming to capture newly generated evidence.
Source: Revista Brasileira de Terapia Intensiva - Category: Intensive Care Source Type: research
More News: American Health | Blogging | Coronavirus | COVID-19 | Diabetes | Ebola | Economic Slowdown | Economics | Economy | Emergency Medicine | Endocrinology | Epidemics | Epidemiology | Family Practices | Health | Health Insurance | Health Management | Healthcare Costs | Hospitals | Hydroxychloroquine | Insulin | Insurance | Insurers | Jobs | Legislation | Medical Billing | Pandemics | Politics | Study | Transplants | Unemployment | Uninsured